Effectiveness of CAR-T treatment toward the potential risk of second malignancies.

MLA

Martino, Massimo, et al. “Effectiveness of CAR-T Treatment toward the Potential Risk of Second Malignancies.” Frontiers in Immunology, May 2024, pp. 1–7. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1384002.

APA

Martino, M., Porto, G., Policastro, G., Alati, C., Loteta, B., Micó, M. C., Argiro’, C., Altomonte, M., Moscato, T., Labate, D., Dattola, V., Rao, C. M., Cogliandro, F., Canale, F. A., Naso, V., Filippelli, G., Iaria, A., & Pitea, M. (2024). Effectiveness of CAR-T treatment toward the potential risk of second malignancies. Frontiers in Immunology, 1–7. https://doi.org/10.3389/fimmu.2024.1384002

Chicago

Martino, Massimo, Gaetana Porto, Giorgia Policastro, Caterina Alati, Barbara Loteta, Maria Caterina Micó, Clizia Argiro’, et al. 2024. “Effectiveness of CAR-T Treatment toward the Potential Risk of Second Malignancies.” Frontiers in Immunology, May, 1–7. doi:10.3389/fimmu.2024.1384002.